Whitehawk Therapeutics, Inc. (WHWK)
3.07
+0.05
(+1.66%)
USD |
NASDAQ |
Nov 06, 10:21
Whitehawk Therapeutics Net Income (Quarterly) : -16.64M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.64M |
| March 31, 2026 | -22.19M |
| December 31, 2025 | -23.25M |
| September 30, 2025 | -17.75M |
| June 30, 2025 | -52.62M |
| March 31, 2025 | 73.02M |
| December 31, 2024 | -18.27M |
| September 30, 2024 | -12.55M |
| June 30, 2024 | -14.58M |
| March 31, 2024 | -18.29M |
| December 31, 2023 | -16.27M |
| September 30, 2023 | -16.30M |
| June 30, 2023 | -17.97M |
| March 31, 2023 | -15.22M |
| December 31, 2022 | -13.91M |
| September 30, 2022 | -14.47M |
| June 30, 2022 | -18.27M |
| March 31, 2022 | -13.86M |
| December 31, 2021 | -15.99M |
| Date | Value |
|---|---|
| September 30, 2021 | -87.09M |
| June 30, 2021 | -1.536M |
| March 31, 2021 | -5.476M |
| December 31, 2020 | 8.02M |
| September 30, 2020 | -2.892M |
| June 30, 2020 | 9.276M |
| March 31, 2020 | -3.919M |
| December 31, 2019 | -4.446M |
| September 30, 2019 | -4.648M |
| June 30, 2019 | -5.684M |
| March 31, 2019 | -8.493M |
| December 31, 2018 | -8.518M |
| September 30, 2018 | 11.54M |
| June 30, 2018 | -5.99M |
| March 31, 2018 | -7.426M |
| December 31, 2017 | -6.235M |
| September 30, 2017 | -4.650M |
| June 30, 2017 | -5.520M |
| March 31, 2017 | -4.996M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 16.64M |
| EPS Diluted (Quarterly) | -0.2008 |
| Enterprise Value | -17.81M |
| Earnings Yield | -36.28% |
| Normalized Earnings Yield | -36.28 |